Sorafenib ethylsulfonate salt, process for preparation and use
US8552197B2 · kind B2 · utility
0Cited by
2References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 12, 2010 |
| Grant date | Oct 8, 2013 |
| Priority date | — |
| Expiry date | Nov 12, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides sorafenib ethane sulphonate, process for its preparation, pharmaceutical composition comprising sorafenib ethane sulphonate and its use for the treatment of cancer. Formula (III).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.